{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T03:34:35Z","timestamp":1764732875282,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tech Coloproctol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s10151-020-02250-5","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T18:04:47Z","timestamp":1591121087000},"page":"883-889","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Mesenchymal stem cells in perianal Crohn\u2019s disease"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6297-9347","authenticated-orcid":false,"given":"H.","family":"Guadalajara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Garc\u00eda-Arranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Dolores","family":"Herreros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6022-2906","authenticated-orcid":false,"given":"K.","family":"Borycka-Kiciak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. L.","family":"Lightner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Garc\u00eda-Olmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,1]]},"reference":[{"key":"2250_CR1","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1046\/j.1365-2036.2003.01793.x","volume":"18","author":"C Dejaco","year":"2003","unstructured":"Dejaco C, Harrer M, Waldhoer T et al (2003) Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. Aliment Pharmacol Ther 18:1113\u20131120","journal-title":"Aliment Pharmacol Ther"},{"key":"2250_CR2","first-page":"533","volume":"79","author":"J Jakobovits","year":"1984","unstructured":"Jakobovits J, Schuster MM (1984) Metronidazole therapy for Crohn\u2019s disease and associated fistulae. Am J Gastroenterol 79:533\u2013540","journal-title":"Am J Gastroenterol"},{"key":"2250_CR3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0016-5085(82)80332-6","volume":"83","author":"LJ Brandt","year":"1982","unstructured":"Brandt LJ, Bernstein LH, Boley SJ, Frank MS (1982) Metronidazole therapy for perineal Crohn\u2019s disease: a follow-up study. Gastroenterology 83:383\u2013387","journal-title":"Gastroenterology"},{"key":"2250_CR4","first-page":"A793","volume":"104","author":"U Turunen","year":"1993","unstructured":"Turunen U, F\u00e4rkkil\u00e4 M, Valtonen V, Sepp\u00e4l\u00e4 K (1993) Long-term outcome of ciprofloxacin treatment in severe perianal or fistulous Crohn\u2019s disease. Gastroenterology 104:A793 (Abst)","journal-title":"Gastroenterology"},{"key":"2250_CR5","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1155\/1993\/610272","volume":"7","author":"MJ Solomon","year":"1993","unstructured":"Solomon MJ, McLeod RS, O\u2019Connor BI, Steinhart AH, Greenberg GR, Cohen Z (1993) Combination ciprofloxacin and metronidazole in severe perianal Crohn\u2019s disease. Can J Gastroenterol 7:571\u2013573","journal-title":"Can J Gastroenterol"},{"key":"2250_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.7326\/0003-4819-123-2-199507150-00009","volume":"122","author":"DC Pearson","year":"1995","unstructured":"Pearson DC, May GR, Fick GH, Sutherland LR (1995) Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 122:132\u2013142","journal-title":"Ann Intern Med"},{"key":"2250_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/BF01318372","volume":"30","author":"BI Korelitz","year":"1985","unstructured":"Korelitz BI, Present DH (1985) Favorable effect of 6-mercaptopurine on fistulae of Crohn\u2019s disease. Dig Dis Sci 30:58\u201364","journal-title":"Dig Dis Sci"},{"key":"2250_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0016-5085(91)90457-V","volume":"101","author":"JJ O\u2019Brien","year":"1991","unstructured":"O\u2019Brien JJ, Bayless TM, Bayless JA (1991) Use of azathioprine or 6-mercaptopurine in the treatment of Crohn\u2019s disease. Gastroenterology 101:39\u201346","journal-title":"Gastroenterology"},{"key":"2250_CR9","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1016\/0016-5085(95)90747-5","volume":"109","author":"WJ Sandborn","year":"1995","unstructured":"Sandborn WJ, van Os EC, Zins BJ, Tremaine WJ, Mays DC, Lipsky JJ (1995) An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn\u2019s disease. Gastroenterology 109:1808\u20131817","journal-title":"Gastroenterology"},{"key":"2250_CR10","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0016-5085(99)70445-2","volume":"117","author":"WJ Sandborn","year":"1999","unstructured":"Sandborn WJ, Tremaine WJ, Wolf DC, Targan SR, Sninsky CA, Sutherland LR et al (1999) Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn\u2019s disease. Gastroenterology 117:527\u2013535","journal-title":"Gastroenterology"},{"key":"2250_CR11","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/NEJMoa030815","volume":"350","author":"BE Sands","year":"2004","unstructured":"Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN et al (2004) Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 350:876\u2013885","journal-title":"N Engl J Med"},{"key":"2250_CR12","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/bjs.6608","volume":"96","author":"PJ van Koperen","year":"2009","unstructured":"van Koperen PJ, Safiruddin F, Bemelman WA, Slors JF (2009) Outcome of surgical treatment for fistula in ano in Crohn's disease. Br J Surg 96:675\u2013679","journal-title":"Br J Surg"},{"key":"2250_CR13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/bjs.4466","volume":"91","author":"GN Buchanan","year":"2004","unstructured":"Buchanan GN, Owen HA, Torkington J, Lunniss PJ, Nicholls RJ, Cohen CR (2004) Long-term outcome following loose-seton technique for external sphincter preservation in complex anal fistula. Br J Surg 91:476\u2013480","journal-title":"Br J Surg"},{"key":"2250_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3393\/ac.2018.11.23.1","volume":"3","author":"M Jeon","year":"2019","unstructured":"Jeon M, Song K, Koo J, Kim S (2019) Evaluation of a seton procedure combined with infliximab therapy (early vs. late) in perianal fistula with Crohn disease. Ann Coloproctol 3:249\u2013253","journal-title":"Ann Coloproctol"},{"key":"2250_CR15","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/apt.14969","volume":"48","author":"S Sebastian","year":"2018","unstructured":"Sebastian S, Black C, Pugliese D et al (2018) The role of multimodal treatment in Crohn\u2019s disease patients with perianal fistula: a multicentre retrospective cohort study. Aliment Pharmacol Ther 48:941\u2013950","journal-title":"Aliment Pharmacol Ther"},{"key":"2250_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1359\/jbmr.1998.13.2.195","volume":"13","author":"DL Thompson","year":"1998","unstructured":"Thompson DL, Lum KD, Nygaard SC, Kuestner RE, Kelly KA, Gimble JM et al (1998) The derivation and characterization of stromal cell lines from the bone marrow of p53\u2212\/\u2212 mice: new insights into osteoblast and adipocyte differentiation. J Bone Miner Res 13:195\u2013204","journal-title":"J Bone Miner Res"},{"key":"2250_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/10245332.1999.11746456","volume":"4","author":"CM Verfaillie","year":"1999","unstructured":"Verfaillie CM, Gupta P, Prosper F, Hurley R, Lundell B, Bhatia R (1999) The hematopoietic microenvironment: stromal extracellular matrix components as growth regulators for human hematopoietic progenitors. Hematology 4:321\u2013333","journal-title":"Hematology"},{"key":"2250_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/107632701300062859","volume":"7","author":"PA Zuk","year":"2001","unstructured":"Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ et al (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211\u2013228","journal-title":"Tissue Eng"},{"key":"2250_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00384-003-0490-3","volume":"18","author":"D Garc\u00eda-Olmo","year":"2003","unstructured":"Garc\u00eda-Olmo D, Garc\u00eda-Arranz M, Garc\u00eda LG, Cuellar ES, Blanco IF, Prianes LA et al (2003) Autologous stem cell transplantation for treatment of rectovaginal fistula in perinatal Crohn's disease: a new cell-based therapy. Int J Colorectal Dis 18:451\u2013454","journal-title":"Int J Colorectal Dis"},{"key":"2250_CR20","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","volume":"388","author":"J Pan\u00e9s","year":"2016","unstructured":"Pan\u00e9s J, Garc\u00eda-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC et al (2016) Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Lancet 388:1281\u20131290","journal-title":"Lancet"},{"key":"2250_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10151-019-02024-8","volume":"23","author":"F Cheng","year":"2019","unstructured":"Cheng F, Huang Z, Li Z (2019) Mesenchymal stem-cell therapy for perianal fistulas in Crohn\u2019s disease: a systematic review and meta-analysis. Tech Coloproctol 23:613\u2013623","journal-title":"Tech Coloproctol"},{"key":"2250_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/jgh3.12141","volume":"3","author":"R Ciccocioppo","year":"2019","unstructured":"Ciccocioppo R, Klersy C, Leffler DA, Rogers R, Bennett D, Corazza GR (2019) Systematic review with meta-analysis: safety and efficacy of local injections of mesenchymal stem cells in perianal fistulas. JGH Open 3:249\u2013260","journal-title":"JGH Open"},{"key":"2250_CR23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10151-019-01994-z","volume":"23","author":"S Choi","year":"2019","unstructured":"Choi S, Jeon BG, Chae G, Lee SJ (2019) The clinical efficacy of stem cell therapy for complex perianal fistulas: a meta-analysis. Tech Coloproctol 23:411\u2013427","journal-title":"Tech Coloproctol"},{"key":"2250_CR24","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.cgh.2018.01.030","volume":"16","author":"MJ Lee","year":"2018","unstructured":"Lee MJ, Parker CE, Taylor SR, Guizzetti L, Feagan BG, Lobo AJ et al (2018) Efficacy of medical therapies for fistulizing Crohn's disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 16:1879\u20131892","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2250_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/DCR.0000000000001093","volume":"61","author":"AL Lightner","year":"2018","unstructured":"Lightner AL, Wang Z, Zubair AC, Dozois EJ (2018) A systematic review and meta-analysis of mesenchymal stem cell injections for the treatment of perianal Crohn's disease: progress made and future directions. Dis Colon Rectum 61:629\u2013640","journal-title":"Dis Colon Rectum"},{"key":"2250_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/ecco-jcc\/jjw169","volume":"11","author":"P Gionchetti","year":"2017","unstructured":"Gionchetti P, Dignass A, Danese S, Magro Dias FJ, Rogler G, Lakatos PL et al (2017) 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: part 2: surgical management and special situations. J Crohns Colitis 11:135\u2013149","journal-title":"J Crohns Colitis"},{"key":"2250_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjy056","volume":"12","author":"WA Bemelman","year":"2018","unstructured":"Bemelman WA, Warusavitarne J, Sampietro GM, Serclova Z, Zmora O, Luglio G (2018) ECCO-ESCP consensus on surgery for Crohn's disease. J Crohns Colitis 12:1\u201316","journal-title":"J Crohns Colitis"},{"key":"2250_CR28","doi-asserted-by":"crossref","unstructured":"Bosc\u00e1 MM, Al\u00f3s R, Maroto N, Gisbert JP, Beltr\u00e1n B, Chaparro M et al (2019) Recommendations of the Crohn's Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn's disease. Gastroenterol Hepatol","DOI":"10.1016\/j.gastre.2019.09.011"},{"key":"2250_CR29","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.4049\/jimmunol.0902023","volume":"184","author":"G Ren","year":"2010","unstructured":"Ren G, Zhao X, Zhang L, Zhang J, L'Huillier A, Ling W et al (2010) Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol 184:2321\u20132328","journal-title":"J Immunol"},{"key":"2250_CR30","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1002\/stem.544","volume":"28","author":"A Krasnodembskaya","year":"2010","unstructured":"Krasnodembskaya A, Song Y, Fang X, Gupta N, Serikov V, Lee JW et al (2010) Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 28:2229\u20132238","journal-title":"Stem Cells"},{"key":"2250_CR31","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/leu.2010.310","volume":"25","author":"R Meisel","year":"2011","unstructured":"Meisel R, Brockers S, Heseler K, Degistirici O, Bulle H, Woite C et al (2011) Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase. Leukemia 25:648\u2013654","journal-title":"Leukemia"},{"key":"2250_CR32","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2017.12.020","volume":"154","author":"J Pan\u00e9s","year":"2018","unstructured":"Pan\u00e9s J, Garc\u00eda-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC et al (2018) Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn's disease. Gastroenterology 154:1334\u20131342","journal-title":"Gastroenterology"}],"container-title":["Techniques in Coloproctology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-020-02250-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10151-020-02250-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-020-02250-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T05:38:16Z","timestamp":1622525896000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10151-020-02250-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["2250"],"URL":"https:\/\/doi.org\/10.1007\/s10151-020-02250-5","relation":{},"ISSN":["1123-6337","1128-045X"],"issn-type":[{"type":"print","value":"1123-6337"},{"type":"electronic","value":"1128-045X"}],"subject":[],"published":{"date-parts":[[2020,6,1]]},"assertion":[{"value":"16 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Garc\u00eda-Olmo D is a member of the Advisory Board of Tigenix S. A. U. and has received fees from Takeda. Garc\u00eda-Olmo D and Garcia-Arranz M have applied for two patents related to this study entitled \u201cIdentification and isolation of multipotent cells from nonosteochondral mesenchymal tissue\u201d (WO 2006\/057649) and \u201cUse of adipose tissue-derived stromal stem cells in treating fistula\u201d (WO 2006\/136244). Garc\u00eda-Olmo D, Guadalajara H, and Garcia-Arranz M are shareholders of Biosurgery, an educational company that provides services to Takeda Pharmaceutical. Amy L. is a consultant for Takeda Pharmaceutical.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}